You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 782-F Pseudoprogression and subsequent shrinkage of refractory/relapsed pediatric solid tumors induced by GAIA-102: an interim report of the single-agent cohort in Phase I clinical trial

Article metrics

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Clinical Trial In Progress
782-F Pseudoprogression and subsequent shrinkage of refractory/relapsed pediatric solid tumors induced by GAIA-102: an interim report of the single-agent cohort in Phase I clinical trial

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202301777
Dec 20233373
Jan 20242000
Feb 20242003
Mar 20243001
Apr 20241600
May 20241602
Jun 20244604
Jul 2024600
Aug 20242000
Sep 20243003
Oct 20242806
Nov 20243001
Dec 20242605
Jan 20253905
Feb 20251403
Mar 2025007
Apr 2025002
May 2025004
Jun 2025002
Total37418458